8 results on '"Jaffe, Marc G."'
Search Results
2. Fatores impulsionadores e scorecards para melhorar o controle da hipertensão arterial na atenção primária: recomendações do Grupo de Inovação da Iniciativa HEARTS nas Américas.
- Author
-
Brettler, Jeffrey W., Giraldo Arcila, Gloria P., Aumala, Teresa, Best, Allana, Campbell, Norm R. C., Cyr, Shana, Gamarra, Angelo, Jaffe, Marc G., Jimenez De la Rosa, Mirna, Maldonado, Javier, Neira Ojeda, Carolina, Haughton, Modesta, Malcolm, Taraleen, Perez, Vivian, Rodriguez, Gonzalo, Rosende, Andres, Valdes Gonzalez, Yamile, Wood, Peter W., Zuniga, Eric, and Ordunez, Pedro
- Subjects
- *
HEALTH facilities , *BLOOD pressure measurement , *MEDICAL quality control , *CONTINUUM of care , *MEDICAL protocols - Abstract
Background. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the Americas, and hypertension is the most significant modifiable risk factor. However, hypertension control rates remain low, and CVD mortality is stagnant or rising after decades of continuing reduction. In 2016, the World Health Organization (WHO) launched the HEARTS technical package to improve hypertension control. The Pan American Health Organization (PAHO) designed the HEARTS in the Americas Initiative to improve CVD risk management, emphasizing hypertension control, to date implemented in 21 countries. Methods. To advance implementation, an interdisciplinary group of practitioners was engaged to select the key evidence-based drivers of hypertension control and to design a comprehensive scorecard to monitor their implementation at primary care health facilities (PHC). The group studied high-performing health systems that achieve high hypertension control through quality improvement programs focusing on specific process measures, with regular feedback to providers at health facilities. Findings. The final selected eight drivers were categorized into five main domains: (1) diagnosis (blood pressure measurement accuracy and CVD risk evaluation); (2) treatment (standardized treatment protocol and treatment intensification); (3) continuity of care and follow-up; (4) delivery system (team-based care, medication refill), and (5) system for performance evaluation. The drivers and recommendations were then translated into process measures, resulting in two interconnected scorecards integrated into the HEARTS in the Americas monitoring and evaluation system. Interpretation. Focus on these key hypertension drivers and resulting scorecards, will guide the quality improvement process to achieve population control goals at the participating health centers in HEARTS implementing countries. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Diretrizes de 2021 da Organização Mundial da Saúde sobre o tratamento medicamentoso da hipertensão arterial: repercussões para as políticas na Região das Américas.
- Author
-
Campbell, Norm R. C., Paccot Burnens, Melanie, Whelton, Paul K., Angell, Sonia Y., Jaffe, Marc G., Cohn, Jennifer, Espinosa Brito, Alfredo, Irazola, Vilma, Brettler, Jeffrey W., Roccella, Edward J., Maldonado Figueredo, Javier Isaac, Rosende, Andres, and Ordunez., Pedro
- Subjects
- *
BLOOD pressure , *HEALTH equity , *CARDIOVASCULAR diseases , *DRUG therapy , *CAUSES of death - Abstract
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Factores impulsores y métodos de puntuación para mejorar el control de la hipertensión en la práctica clínica de la atención primaria: recomendaciones del grupo de innovación de HEARTS en las Américas.
- Author
-
Brettler, Jeffrey W., Giraldo Arcila, Gloria P., Aumala, Teresa, Best, Allana, Campbell, Norm R. C., Cyr, Shana, Gamarra, Angelo, Jaffe, Marc G., Jimenez De la Rosa, Mirna, Maldonado, Javier, Neira Ojeda, Carolina, Haughton, Modesta, Malcolm, Taraleen, Perez, Vivian, Rodriguez, Gonzalo, Rosende, Andres, Valdes Gonzalez, Yamile, Wood, Peter W., Zuñigas, Eric, and Ordunez, Pedro
- Subjects
- *
HEALTH facilities , *BLOOD pressure measurement , *MEDICAL quality control , *CONTINUUM of care , *MEDICAL protocols - Abstract
Background. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the Americas, and hypertension is the most significant modifiable risk factor. However, hypertension control rates remain low, and CVD mortality is stagnant or rising after decades of continuing reduction. In 2016, the World Health Organization (WHO) launched the HEARTS technical package to improve hypertension control. The Pan American Health Organization (PAHO) designed the HEARTS in the Americas Initiative to improve CVD risk management, emphasizing hypertension control, to date implemented in 21 countries. Methods. To advance implementation, an interdisciplinary group of practitioners was engaged to select the key evidence-based drivers of hypertension control and to design a comprehensive scorecard to monitor their implementation at primary care health facilities (PHC). The group studied high-performing health systems that achieve high hypertension control through quality improvement programs focusing on specific process measures, with regular feedback to providers at health facilities. Findings. The final selected eight drivers were categorized into five main domains: (1) diagnosis (blood pressure measurement accuracy and CVD risk evaluation); (2) treatment (standardized treatment protocol and treatment intensification); (3) continuity of care and follow-up; (4) delivery system (team-based care, medication refill), and (5) system for performance evaluation. The drivers and recommendations were then translated into process measures, resulting in two interconnected scorecards integrated into the HEARTS in the Americas monitoring and evaluation system. Interpretation. Focus on these key hypertension drivers and resulting scorecards, will guide the quality improvement process to achieve population control goals at the participating health centers in HEARTS implementing countries. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Directrices de la Organización Mundial de la Salud del 2021 sobre el tratamiento farmacológico de la hipertensión: implicaciones de política para la Región de las Américas.
- Author
-
Campbell, Norm R. C., Paccot Burnens, Melanie, Whelton, Paul K., Angell, Sonia Y., Jaffe, Marc G., Cohn, Jennifer, Espinosa Brito, Alfredo, Irazola, Vilma, Brettler, Jeffrey W., Roccella, Edward J., Maldonado Figueredo, Javier Isaac, Rosende, Andres, and Ordunez, Pedro
- Subjects
- *
BLOOD pressure , *HEALTH equity , *CARDIOVASCULAR diseases , *DRUG therapy , *CAUSES of death - Abstract
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an over-arching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Integrating hypertension and diabetes management in primary health care settings: HEARTS as a tool.
- Author
-
Flood, David, Edwards, Elizabeth W., Giovannini, David, Ridley, Emily, Rosende, Andres, Herman, William H., Jaffe, Marc G., and DiPette, Donald J.
- Subjects
- *
PRIMARY health care , *MEDICAL care , *GLOBAL burden of disease , *HYPERTENSION , *DIABETES , *HEART tumors - Abstract
Hypertension and diabetes are modifiable cardiovascular disease (CVD) risk factors that contribute to nearly one-third of all deaths in the Americas Region each year (2.3 million deaths). Despite advances in the detection and clinical management of hypertension and diabetes, there are substantial gaps in their implementation globally and in the Region. The considerable overlap in risk factors, prognosis, and treatment of hypertension and diabetes creates a unique opportunity for a unified implementation model for management at the population level. This report highlights one such high-profile effort, the Pan American Health Organization's "HEARTS in the Americas" program, based on the World Health Organization's HEARTS Technical Package for Cardiovascular Disease Management in Primary Health Care. The HEARTS program aims to improve the implementation of preventive CVD care in primary health systems using six evidence-based, pragmatic components: Healthy-lifestyle counseling, Evidence-based protocols, Access to essential medicines and technology, Risk-based CVD management, Team-based care, and Systems for monitoring. To date, HEARTS implementation projects have focused primarily on hypertension given that it is the leading modifiable CVD risk factor and can be treated cost-effectively. The objective of this report is to describe opportunities for integration of diabetes clinical care and policy within the HEARTS hypertension framework. A substantial global burden of disease could be averted with integrated primary care management of these conditions. Thus, there is an urgency in applying lessons from HEARTS to close these implementation gaps and improve the integrated detection, treatment, and control of diabetes and hypertension. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care.
- Author
-
Ordunez, Pedro, Campbell, Norm R. C., Giraldo Arcila, Gloria P., Angell, Sonia Y., Lombardi, Cintia, Brettler, Jeffrey W., Rodriguez Morales, Yenny A., Connell, Kenneth L., Gamarra, Angelo, DiPette, Donald J., Rosende, Andres, Jaffe, Marc G., Rodriguez, Libardo, Piñeiro, Daniel J., Martinez, Ramon, and Sharman, James E.
- Subjects
- *
DISEASE management , *CARDIOVASCULAR diseases , *CARDIOVASCULAR diseases risk factors , *PRIMARY care , *PRIMARY health care - Abstract
Global Hearts is the flagship initiative of the World Health Organization to reduce the burden of cardiovascular diseases, the leading cause of death and disability worldwide. HEARTS in the Americas Initiative is the regional adaptation that envisions HEARTS as the model for cardiovascular disease risk management, including hypertension and diabetes, in primary health care in the Americas by 2025. This initiative is entering its sixth year of implementation and now includes 22 countries and 1 380 primary health care centers. The objectives of this report are three-fold. First, it describes the emergence and the main elements of HEARTS in the Americas. Secondly, it summarizes the main innovations developed to catalyze and sustain implementation of the initiative. These innovations include: a) introduction of hypertension control drivers; b) development of a comprehensive and practical clinical pathway; c) development of a strategy to improve the accuracy of blood pressure measurement; d) creation of a monitoring and evaluation platform; and e) development of a standardized set of training and education resources. Thirdly, this report discusses future priorities of the initiative. The goal of implementing these innovative and pragmatic solutions is to create a more effective health system and shift the focus of cardiovascular and hypertension programs from the highly specialized care level to primary health care. In addition, HEARTS in the Americas can serve as a model for more comprehensive, effective, and sustainable noncommunicable disease prevention and treatment practices. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. HEARTS en las Américas: innovaciones para mejorar el manejo de la hipertensión y del riesgo cardiovascular en la atención primaria.
- Author
-
Ordunez, Pedro, Campbell, Norm R. C., Giraldo Arcila, Gloria P., Angell, Sonia Y., Lombardi, Cintia, Brettler, Jeffrey W., Rodríguez Morales, Yenny A., Connell, Kenneth L., Gamarra, Angelo, DiPette, Donald J., Rosende, Andres, Jaffe, Marc G., Rodríguez, Libardo, Piñeiro, Daniel J., Martínez, Ramón, and Sharman, James E.
- Subjects
- *
CARDIOVASCULAR disease prevention , *HYPERTENSION , *PREDICTIVE tests , *PRIMARY health care , *QUALITY assurance , *COMMUNITY-based social services , *BLOOD pressure measurement , *DIFFUSION of innovations - Abstract
Global Hearts is the flagship initiative of the World Health Organization to reduce the burden of cardiovascular diseases, the leading cause of death and disability worldwide. HEARTS in the Americas Initiative is the regional adaptation that envisions HEARTS as the model for cardiovascular disease risk management, including hypertension and diabetes, in primary health care in the Americas by 2025. This initiative is entering its sixth year of implementation and now includes 22 countries and 1 380 primary health care centers. The objectives of this report are three-fold. First, it describes the emergence and the main elements of HEARTS in the Americas. Secondly, it summarizes the main innovations developed to catalyze and sustain implementation of the initiative. These innovations include: a) introduction of hypertension control drivers; b) development of a comprehensive and practical clinical pathway; c) development of a strategy to improve the accuracy of blood pressure measurement; d) creation of a monitoring and evaluation platform; and e) development of a standardized set of training and education resources. Thirdly, this report discusses future priorities of the initiative. The goal of implementing these innovative and pragmatic solutions is to create a more effective health system and shift the focus of cardiovascular and hypertension programs from the highly specialized care level to primary health care. In addition, HEARTS in the Americas can serve as a model for more comprehensive, effective, and sustainable noncommunicable disease prevention and treatment practices. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.